A total of 120 patients were observed to exhibit abnormal FDG-PET/CT signaling, but 38 of these were subsequently investigated by prostate biopsy as a consequence of an abnormal total PSA serum level determination and/or the clinical suspicion of cancer at DRE (15). Here, KLK3 is linked to cancer.